Growth Hormone Peptides

• 83-amino acid analog with enhanced potency (~3x native IGF-1) and extended half-life (20-30 hours)
• Engineered for reduced IGFBP binding, allowing sustained IGF-1R activation without sequestration
• Validated in 22+ publications across cardiovascular, fetal growth, gastrointestinal, and cell culture research

• Oral GH Secretagogue: Non-peptide ghrelin mimetic (C₂₇H₃₆N₄O₅S), >60% bioavailability
• GHS-R1a Agonist: High affinity (pKi = 8.14, EC50 = 1.3 nM), sustained GH-IGF-1 elevation
• Clinical Evidence: 30-year history, >1,000 subjects, Phase 3 development for pediatric GHD

Human Chorionic Gonadotropin (hCG) - LHCGR agonist activating cAMP/PKA signaling cascades. Heterodimeric glycoprotein hormone. Purity ≥95%. Research use only.

• Master Reproductive Regulator: C-terminal decapeptide (YNWNSFGLRF-NH2), ≥95% purity
• KISS1R/GPR54 Agonist: 8-fold higher receptor affinity than kisspeptin-54 (Ki = 0.042 nM)
• GnRH Pulse Generator: Most potent GnRH neuron stimulator, 4-minute human plasma half-life

PEG-MGF (PEGylated Mechano Growth Factor) is a synthetic, stabilized form of the 24-amino acid MGF E-domain peptide derived from the IGF-1Ec splice variant. Research shows it activates satellite cells, promotes myoblast proliferation via MAPK-ERK1/2 signaling, and demonstrates neuroprotective effects through PKCε/Nrf2/HO-1 pathways.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum sagittis orci ac odio dictum tincidunt.